850
Views
12
CrossRef citations to date
0
Altmetric
Case Report

Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency

, BS, NREMT, , NREMT, , NREMT, , MD & , MD, MS, NRP
Pages 212-216 | Received 12 Aug 2016, Accepted 26 Dec 2016, Published online: 27 Jan 2017

References

  • Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths–United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382.
  • Hawk KF, Vaca FE, D'Onofrio G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88:235–245.
  • Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–574.
  • Cicero TJ, Ellis MS, Surratt HL, et al. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71:821–826.
  • Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. 2013;132:95–100.
  • Han B, Compton WM, Jones CM, et al. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. JAMA. 2015;314(14):1468–1478.
  • McCabe SE, West BT, Teter CJ, et al. Trends in medical use, diversion, and nonmedical use of prescription medications among college students from 2003 to 2013: connecting the dots. Addict Behav. 2014;39:1176–1182.
  • Brandt SA, Taverna EC, Hallock RM. A survey of nonmedical use of tranquilizers, stimulants, and pain relievers among college students: patterns of use among users and factors related to abstinence in non-users. Drug Alcohol Depend. 2014;143:272–276.
  • Rozenbroek K, Rothstein WG. Medical and nonmedical users of prescription drugs among college students. J Am Coll Health. 2011;59:358–363.
  • White A, Hingson R. The burden of alcohol use: excessive alcohol consumption and related consequences among college students. Alcohol Res. 2013;35(2):201–218.
  • Fisher J, Ray A, Savett SC, et al. Collegiate-based emergency medical services (EMS): a survey of EMS systems on college campuses. Prehosp Disaster Med. 2005;21:91–96.
  • Boom M, Niesters M, Sarton E, et al. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18(37):5994–6004.
  • Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155.
  • Radke JB, Owen KP, Sutter ME, et al. The effects of opioids on the lung. Clin Rev Allergy Immunol. 2014;46(1):54–64.
  • Boom M, Niesters M, Sarton E, et al. Non-analgesic effects of opioids: opioid-induced respiratory depression. Curr Pharm Des. 2012;18:5994–6004.
  • Fishman J, Roffwarg H, Hellman L. Disposition of naloxone-7,8,3 H in normal and narcotic-dependent men. J Pharmacol Exp Ther. 1973;187:575–580.
  • Berkowitz BA. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone. Clin Pharmacokinet. 1976;1:219–230.
  • van Dorp E, Yassen A, Dahan A. Naloxone treatment in opioid addiction: the risks and benefits. Expert Opin Drug Saf. 2007;6(2):125–132.
  • Knowlton A, Weir BW, Hazzard F, et al. EMS runs for suspected opioid overdose: implications for surveillance and prevention. Prehosp Emerg Care. 2013;17:317–329.
  • Lindstrom HA, Clemency BM, Snyder R, et al. Prehospital naloxone administration as a public health surveillance tool: a retrospective validation study. Prehosp Disaster Med. 2015 Aug;30(4):385–389.
  • Centers for Disease Control and Prevention. Community-based opioid overdose prevention programs providing naloxone – United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:101–105.
  • Rando J, Broering D, Olson JE, et al. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33(9):1201–1204.
  • Lenton S, Dietze P, Olsen A. Working together: expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. Drug Alcohol Rev. 2015;34(4):404–411.
  • Robinson A, Wermeling DP. Intranasal naloxone administration for treatment of opioid overdose. Am J Health Syst Pharm. 2014;71(24):2129–2135.
  • Robertson TM, Hendey GW, Stroh G, et al. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009;13:512–515.
  • National Highway Traffic Safety Administration. National EMS scope of practice model. Report No. DOT HS 810 657. 2007. Available at: http://www.ems.gov/education/EMSScope.pdf. Accessed August 5, 2016.
  • Davis CS, Southwell JK, Niehaus VR, et al. Emergency medical services naloxone access: a national systematic legal review. Acad Emerg Med. 2014;21:1173–1177.
  • Davis CS, Ruiz S, Glynn P, et al. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. Am J Public Health. 2014;104:e7–e9.
  • Davis CS, Carr D, Southwell JK, et al. Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration. Am J Public Health. 2015;105:1530–1537.
  • Clark WR Jr. Emergency medical services education and licensure – a road map for the future. J La State Med Soc. 2009;161:290–292.
  • Belz D, Lieb J, Rea T, et al. Naloxone use in a tiered-response emergency medical services system. Prehosp Emerg Care. 2006;10:468–471.
  • District of Columbia Fire and EMS Department. Emergency medical services manual and pre-hospital treatment protocols. Washington, DC: Government of the District of Columbia; 2014.
  • Secretary of the District of Columbia. D.C. Municipal regulations, Chapter 29–526. Washington, DC: Government of the District of Columbia; 2013.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.